ISTDP for Patients with Treatment Resistance PPS

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Somatic Symptom DisorderPersistent Physical SymptomsFunctional Somatic SyndromeFunctional Somatic DisorderMedically Unexplained Symptoms
Interventions
BEHAVIORAL

Individual intensive short term psychodynamic therapy

ISTDP aims to help patients explore and process unconscious emotions, particularly those linked to past trauma or unresolved conflicts, that may be contributing to their physical symptoms. Patients are guided to identify and express repressed feelings such as anger, grief, or fear. The therapist actively engages the patient in a focused and intensive manner, helping them to recognize emotional defenses, break through resistance, and experience these emotions directly in the therapeutic setting.

Trial Locations (1)

10691

Stockholm University, Stockholm

All Listed Sponsors
lead

Daniel Maroti

OTHER

NCT06682104 - ISTDP for Patients with Treatment Resistance PPS | Biotech Hunter | Biotech Hunter